February 1st, 2013|
February 1, 2013
Both the Consumer Product Safety Commission (CPSC) and its Canadian counterpart, Health Canada, have partnered with Novartis Consumer Health Inc. to conduct a voluntary recall of the company’s Triaminic® and Theraflu Warming Relief® Syrups. According to a CPSC press release, the recall is being conducted due to packaging defects that could be hazardous to consumers.
The recall affects thousands of bottles of the products and is being conducted because the childproof caps can malfunction. The defective packaging can allow children to remove the cap with a tamper-proof seal still in place, which can lead to an unintentional ingestion of the medication. Taking too much of the drug can lead to acute liver failure or death, due to the active ingredients acetaminophen and diphenhydramine in the product.
So far, twelve instances of the Defective Product being opened by a child have been reported, with four instances of a child consuming the product unsupervised being recorded. Luckily, only one of the children required medical attention.
Those in possession of the defective product have been instructed to dispose of the product immediately and to contact Novartis to receive a complete refund of the purchase price.
The Ohio Personal Injury Lawyers at the law firm of Nurenberg, Paris, Heller & McCarthy understand how dangerous the use of a defective product can be and encourage anyone who has been seriously harmed by use of a product or device that did not properly function to discuss their case with an attorney immediately.